SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-074905
Filing Date
2015-10-08
Accepted
2015-10-08 19:16:55
Documents
2
Period of Report
2015-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2102
2 POA DOCUMENT poa.txt EX-24.3_609428 5319
  Complete submission text file 0001209191-15-074905.txt   9064
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142
Business Address
Kress Jean-Paul (Reporting) CIK: 0001654979 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 151151772